Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians

BACKGROUND: With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become increasingly available in ambulatory care. Little is known about the knowledge and attitudes of healthcare providers who are in charge of dispensing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbier, Liese, Vandenplas, Yannick, Simoens, Steven, Declerck, Paul, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218462/
https://www.ncbi.nlm.nih.gov/pubmed/34158128
http://dx.doi.org/10.1186/s40545-021-00330-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218462/
https://www.ncbi.nlm.nih.gov/pubmed/34158128
http://dx.doi.org/10.1186/s40545-021-00330-x

Ejemplares similares